Literature DB >> 10504372

Experimental study of intraperitoneal suramin on the healing of colonic anastomoses.

J M Hendriks1, G Hubens, F L Wuyts, P Vermeulen, A Hubens, E Eyskens.   

Abstract

INTRODUCTION: The effect of the antiangiogenic agent suramin on the healing of colonic anastomoses was studied in a rat model.
METHODS: Rats underwent an end-to-end colonic anastomosis and its healing was tested by measuring bursting pressure, hydroxyproline content and number of newly formed vessels. For the bursting pressure experiment suramin was given intraperitoneally in a dose of 200 mg/kg (maximal tolerable dose) and 100 mg/kg. Hydroxyproline content and vessel density were only tested at 100 mg/kg since the toxicity at this dose was lower whereas bursting pressure was still diminished.
RESULTS: There were no deaths. On the fourth day after operation bursting pressure in the control group was significantly higher than that in rats treated with suramin 200 mg/kg (P = 0.006) and 100 mg/kg (P = 0.002). Rupture occurred at the anastomotic line. On day 7, this difference was not statistically significant. Four days after the operation, the hydroxyproline content and vessel density were significantly below that in control segments (hydroxyproline: 10.3 versus 7.8 microg per mg dry weight; vessel content: 85.7 versus 49.6 vessels per x 100 field for control and suramin-treated rats respectively). On the seventh day no difference in hydroxyproline levels was seen but the vessel density was still diminished significantly (P = 0.04).
CONCLUSION: Experimentally, suramin significantly inhibits and delays healing of colonic anastomoses. Presented in part to the XXXII Congress of the European Society for Surgical Research in Corfu, Greece, May 1997

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504372     DOI: 10.1046/j.1365-2168.1999.01223.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Tumour angiogenesis: the relevance to surgeons.

Authors:  G K Atkin; A Chopada
Journal:  Ann R Coll Surg Engl       Date:  2006-10       Impact factor: 1.891

2.  Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model.

Authors:  Julian W Mall; Wolfgang Schwenk; Andreas W Philipp; Rolf Büttemeyer; Christian Pollmann
Journal:  World J Surg       Date:  2003-09-04       Impact factor: 3.352

3.  Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead.

Authors:  M Mangoni; M-C Vozenin; G Biti; E Deutsch
Journal:  Br J Cancer       Date:  2012-06-12       Impact factor: 7.640

4.  Effects of the histamine H2 receptor antagonist famotidine on the healing of colonic anastomosis in rats.

Authors:  Aydin Inan; Meral Sen; Onder Sürgit; Metin Ergin; Mikdat Bozer
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

5.  Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.

Authors:  Su Jin Jeong; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; June Myung Kim
Journal:  Crit Care       Date:  2013-05-27       Impact factor: 9.097

6.  Bevacizumab is associated with delayed anastomotic leak after low anterior resection with preoperative radiotherapy for rectal cancer: a case report.

Authors:  Erika Machida; Yasuyuki Miyakura; Jun Takahashi; Sawako Tamaki; Hideki Ishikawa; Fumi Hasegawa; Rina Kikugawa; Shingo Tsujinaka; Alan Kawarai Lefor; Toshiki Rikiyama
Journal:  Surg Case Rep       Date:  2019-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.